Cerebrospinal Fluid Amyloid-β (Aβ) as an Effect Biomarker for Brain Aβ Lowering Verified by Quantitative Preclinical AnalysesYasong Lu, Martin Pettersson, Kathleen M. Wood et al.|Journal of Pharmacology and Experimental Therapeutics|2012Cited by 36
Quantitative Pharmacokinetic/Pharmacodynamic Analyses Suggest That the 129/SVE Mouse Is a Suitable Preclinical Pharmacology Model for Identifying Small-Molecule γ-Secretase InhibitorsYasong Lu, David Riddell, Liming Zhang et al.|Journal of Pharmacology and Experimental Therapeutics|2011Cited by 24